Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-12 Purchase | 2022-05-16 08:32 am | Nuvectis Pharma Inc. | NVCT | Kaplan Matthew L. Director | 3,000 | $16.88 | $50,633 | 35,760 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-13 Option Award | 2024-06-13 4:22 pm | N/A N/A | Nuvectis Pharma Inc. | NVCT | Kaplan Matthew L. Director | 30,000 | $0 | 83,760 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-20 08:16 am | N/A N/A | Nuvectis Pharma Inc. | NVCT | Kaplan Matthew L. Director | 18,000 | $0 | 53,760 (Direct) | View |
| 2022-04-01 Option Award | 2022-04-05 4:48 pm | 2023-04-01 2032-04-01 | Nuvectis Pharma Inc. | NVCT | Kaplan Matthew L. Director | 15,000 | $0 | 15,000 (Direct) | View |
Ownership | 2022-02-08 08:32 am | N/A N/A | Nuvectis Pharma Inc. | NVCT | Kaplan Matthew L. Director | 0 | $0 | 62,010 (Direct) | View |